Insider Trading Summary for Marinus Pharmaceuticals, Inc. (MRNS): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-Jan-24 4:22 PM View:	18-Jan-24 Grant 0	Mayleben Timothy M Director		Marinus Pharmaceuticals, Inc. - MRNS	26% 17.48K to 22.07K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 4:25 PM View:	18-Jan-24 Grant 0	Fischer Seth H.Z. Director		Marinus Pharmaceuticals, Inc. - MRNS	76% 6.03K to 10.63K	0	0	--	--	Show Txns Hide Txns

21-Feb-24 4:06 PM View:	16-Feb-24 Market Sale (Planned) ($28.08K)	Hulihan Joseph Chief Medical Officer		Marinus Pharmaceuticals, Inc. - MRNS	32% 50.52K to 66.64K	0	($55.67K) (11%)	--	$9.55 - $9.98	Show Txns Hide Txns

19-Jan-24 4:26 PM View:	18-Jan-24 Grant 0	Ezickson Elan Director		Marinus Pharmaceuticals, Inc. - MRNS	82% 5.6K to 10.2K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 4:23 PM View:	18-Jan-24 Grant 0	Austin Charles Director		Marinus Pharmaceuticals, Inc. - MRNS	87% 5.28K to 9.88K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 4:23 PM View:	18-Jan-24 Grant 0	Nochur Sara Director		Marinus Pharmaceuticals, Inc. - MRNS	72% 6.35K to 10.95K	0	0	--	--	Show Txns Hide Txns

27-Mar-24 11:55 AM View:	27-Mar-24 Option Exercise $214.00K	Braunstein Scott Chairman and CEO Director		Marinus Pharmaceuticals, Inc. - MRNS	64% 167.21K to 273.51K	0	($179.03K) (11%)	--	$9.55 - $9.94	Show Txns Hide Txns

22-Feb-24 4:05 PM View:	20-Feb-24 Market Sale (Planned) ($20.58K)	Shafer Christina Chief Commercial Officer		Marinus Pharmaceuticals, Inc. - MRNS	40% 43.02K to 60.31K	0	($20.58K) (5%)	--	$9.56	Show Txns Hide Txns

19-Jan-24 4:27 PM View:	18-Jan-24 Grant 0	Silverstein Christine Berni Director		Marinus Pharmaceuticals, Inc. - MRNS	64% 7.2K to 11.8K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 4:27 PM View:	18-Jan-24 Grant 0	Johnson Marvin Director		Marinus Pharmaceuticals, Inc. - MRNS	64% 7.2K to 11.8K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 4:28 PM View:	18-Jan-24 Grant 0	Noonberg Sarah B. Director		Marinus Pharmaceuticals, Inc. - MRNS	100% 0 to 11.8K	0	0	--	--	Show Txns Hide Txns

22-Feb-24 4:05 PM View:	20-Feb-24 Market Sale (Planned) ($18.13K)	Manning Martha E SVP, GEN. COUNSEL & CORP. SEC.		Marinus Pharmaceuticals, Inc. - MRNS	50% 35.2K to 52.97K	0	($18.13K) (5%)	--	$9.57	Show Txns Hide Txns

21-Feb-24 4:05 PM View:	16-Feb-24 Market Sale (Planned) ($30.83K)	Pfanstiel Steven CFO AND COO		Marinus Pharmaceuticals, Inc. - MRNS	38% 52.13K to 71.7K	0	($30.83K) (6%)	--	$9.97	Show Txns Hide Txns

Buy:	0	--
Sell:	($304.24K)	$9.55 - $9.98

Marinus Pharmaceuticals, Inc. (MRNS)

Last Year

03-May-23 -- 02-May-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

03-May-22 -- 02-May-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades